Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ITCI Intra-Cellular Therapies, Inc. daily Stock Chart
ITCI [NASD]
Intra-Cellular Therapies, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-2.69 Insider Own2.60% Shs Outstand64.88M Perf Week-3.84%
Market Cap1.49B Forward P/E- EPS next Y-3.73 Insider Trans28.47% Shs Float61.23M Perf Month-2.50%
Income-147.90M PEG- EPS next Q-0.81 Inst Own67.70% Short Float7.12% Perf Quarter142.83%
Sales- P/S- EPS this Y-32.40% Inst Trans-4.04% Short Ratio1.45 Perf Half Y171.14%
Book/sh4.11 P/B5.60 EPS next Y-35.10% ROA-45.80% Target Price49.38 Perf Year75.32%
Cash/sh3.94 P/C5.85 EPS next 5Y- ROE-54.30% 52W Range6.75 - 43.56 Perf YTD-32.91%
Dividend- P/FCF- EPS past 5Y-12.70% ROI- 52W High-49.14% Beta1.96
Dividend %- Quick Ratio7.80 Sales past 5Y- Gross Margin- 52W Low228.23% ATR1.24
Employees73 Current Ratio7.80 Sales Q/Q- Oper. Margin- RSI (14)32.72 Volatility5.40% 4.86%
OptionableYes Debt/Eq0.00 EPS Q/Q16.80% Profit Margin- Rel Volume0.20 Prev Close23.02
ShortableYes LT Debt/Eq0.00 EarningsFeb 26 Payout- Avg Volume3.00M Price22.16
Recom1.60 SMA20-2.90% SMA50-9.13% SMA20061.79% Volume569,629 Change-3.76%
Feb-20-20Initiated Evercore ISI Outperform
Jan-31-20Downgrade JP Morgan Overweight → Neutral $26
Dec-24-19Reiterated Canaccord Genuity Buy $29 → $65
Aug-12-19Initiated Jefferies Buy $16
Feb-26-18Initiated JP Morgan Overweight
Feb-08-18Initiated RBC Capital Mkts Outperform $33
Dec-15-17Initiated Canaccord Genuity Buy $31
Nov-08-17Upgrade SunTrust Hold → Buy
Sep-07-17Upgrade Piper Jaffray Neutral → Overweight
Aug-30-17Upgrade Ladenburg Thalmann Neutral → Buy
Aug-24-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Aug-23-17Upgrade Leerink Partners Mkt Perform → Outperform
May-02-17Downgrade Leerink Partners Outperform → Mkt Perform
May-02-17Downgrade Ladenburg Thalmann Buy → Neutral
May-01-17Downgrade Piper Jaffray Overweight → Neutral
Dec-16-16Initiated Cantor Fitzgerald Overweight
Sep-29-16Reiterated RBC Capital Mkts Outperform $74 → $49
Sep-29-16Downgrade SunTrust Buy → Neutral
Sep-29-16Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-02-16Initiated Piper Jaffray Overweight
Feb-25-20 08:45AM  Why Intra-Cellular Therapies (ITCI) Might Surprise This Earnings Season Zacks
Feb-24-20 08:00AM  Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast GlobeNewswire -6.88%
Feb-21-20 04:15PM  Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Feb-20-20 05:00PM  Pivotal Study of CAPLYTA (lumateperone) for the Treatment of Schizophrenia in Adults Published in JAMA Psychiatry GlobeNewswire
Feb-18-20 10:13AM  What Awaits Intra-Cellular Therapies (ITCI) in Q4 Earnings? Zacks
08:00AM  Intra-Cellular Therapies to Present at the 9th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Jan-27-20 12:31PM  Intra-Cellular Therapies (NASDAQ:ITCI) Shareholders Booked A 99% Gain In The Last Year Simply Wall St.
Jan-21-20 08:50AM  Implied Volatility Surging for Intra-Cellular (ITCI) Stock Options Zacks
Jan-10-20 09:04AM  Top Ranked Momentum Stocks to Buy for January 10th Zacks
Jan-08-20 08:12AM  The Daily Biotech Pulse: Verastem In-Licenses Chughai's Tumor Drug, Midatech Surges On Positive Study Results Benzinga -15.03%
Jan-07-20 09:47PM  Intra-Cellular Therapies Prices Public Offering of Common Stock GlobeNewswire
07:57AM  The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering Benzinga
Jan-06-20 04:06PM  Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-02-20 08:00AM  Intra-Cellular Therapies to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-31-19 11:36AM  5 Stocks Financial Advisors Are Looking To Buy This Week Insider Monkey
09:02AM  Moving Average Crossover Alert: Intra-Cellular Therapies Zacks
Dec-24-19 09:04AM  Company News For Dec 24, 2019 Zacks +5.42%
08:13AM  Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 24, 2019: TSLA, WCC, ACST, YMAB, ITCI Benzinga
07:24AM  The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict Benzinga
07:06AM  Investors flock to neuro drug makers after FDA approves new schizophrenia drug MarketWatch
Dec-23-19 04:15PM  Why This Highflying Biotech Stock Just Rocketed 194% In Massive Volume Investor's Business Daily +193.49%
07:59AM  UPDATE: Intra-Cellular Therapies stock soars 83% premarket after FDA approves schizophrenia treatment MarketWatch
06:59AM  FDA Approves Intra-Cellular Therapies Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults GlobeNewswire
Dec-22-19 12:08PM  The Week Ahead In Biotech: Correvio, Intra-Cellular Therapies Await FDA Decisions Benzinga
Dec-20-19 10:24AM  Is the Options Market Predicting a Spike in Intra-Cellular Therapies (ITCI) Stock? Zacks
Dec-14-19 09:12PM  Did Hedge Funds Drop The Ball On Intra-Cellular Therapies Inc (ITCI) ? Insider Monkey
Dec-12-19 08:08AM  Does Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Have A Volatile Share Price? Simply Wall St.
07:30AM  Intra-Cellular Therapies Highlights Lumateperone Presentations at the 58th Annual Meeting of the American College of Neuropsychopharmacology GlobeNewswire
Dec-11-19 08:40AM  Intra-Cellular Therapies (ITCI) in Focus: Stock Moves 6.1% Higher Zacks
Dec-09-19 09:18AM  All Eyes on These 3 Biotech Stocks Ahead of FDA Decisions TipRanks +13.24%
Dec-04-19 08:00AM  Intra-Cellular Therapies to Present Data on Lumateperone and ITI-333 at the 58th Annual Meeting of the American College of Neuropsychopharmacology GlobeNewswire
Nov-21-19 02:31PM  Edited Transcript of ITCI earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents +5.45%
Nov-19-19 09:14AM  Options Traders Expect Huge Moves in Intra-Cellular Therapies (ITCI) Stock Zacks
Nov-11-19 10:16AM  Top Ranked Momentum Stocks to Buy for November 11th Zacks
Nov-09-19 02:27PM  Hedge Funds Have Never Been Less Bullish On Intra-Cellular Therapies Inc (ITCI) Insider Monkey
Nov-05-19 07:30AM  Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2019 Financial Results GlobeNewswire
06:43AM  3 Hot Biotech Stocks With 100% Street Support TipRanks
Oct-30-19 09:29AM  Intra-Cellular Therapies Shares March Higher, Can It Continue? Zacks
Oct-29-19 08:00AM  Intra-Cellular Therapies to Host Third Quarter 2019 Financial Results Conference Call and Webcast GlobeNewswire
Oct-28-19 12:24PM  Companies Like Intra-Cellular Therapies (NASDAQ:ITCI) Are In A Position To Invest In Growth Simply Wall St.
Sep-30-19 08:00AM  Intra-Cellular Therapies to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-27-19 08:58AM  Are Options Traders Betting on a Big Move in Intra-Cellular Therapies (ITCI) Stock? Zacks
08:57AM  Who Has Been Buying Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares? Simply Wall St.
Sep-25-19 07:30AM  Intra-Cellular Therapies Announces Progression to Higher Dose Cohort in ITI-214 Translational Medicine Study in Patients with Heart Failure GlobeNewswire
Sep-20-19 10:02AM  6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day Zacks
Sep-10-19 11:33AM  FDA: No Adcom Meeting For Intra-Cellular's Schizophrenia Drug Benzinga
07:30AM  Intra-Cellular Therapies Provides Lumateperone Regulatory Update GlobeNewswire
Aug-28-19 08:48AM  How Should Investors React To Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) CEO Pay? Simply Wall St.
Aug-19-19 06:00AM  5 Biggest New Drug Approvals Potentially on the Way in 2019 Motley Fool
Aug-07-19 08:00AM  Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2019 Financial Results GlobeNewswire
Aug-06-19 08:00AM  Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference GlobeNewswire
Aug-05-19 07:30AM  Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA GlobeNewswire +8.46%
Jul-24-19 10:58AM  Biotech Stock Roundup: BIIB Q2 Earnings Top & CELG's Otezla Label Expanded Zacks
Jul-23-19 07:30PM  Intra-Cellular Therapies Provides Update on FDA Advisory Committee Meeting for Lumateperone for the Treatment of Schizophrenia GlobeNewswire -31.64%
04:30PM  Why PulteGroup, Intra-Cellular Therapies, and Clear Channel Outdoor Slumped Today Motley Fool
07:11AM  Is Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Potentially Underrated? Simply Wall St.
Jul-09-19 11:10AM  A Look At Benzinga Pro's Most-Searched Tickers For July 9, 2019 Benzinga
09:49AM  Company News For Jul 9, 2019 Zacks
09:45AM  Intra-Cellular Therapies' Candidate Fails in Phase III Study Zacks
Jul-08-19 04:51PM  Why Deutsche Bank, Intra-Cellular Therapies, and Coherus BioSciences Slumped Today Motley Fool -13.08%
01:50PM  A Look At Benzinga Pro's Most-Searched Tickers For July 8, 2019 Benzinga
11:34AM  Why Intra-Cellular Therapies Is Tanking Today Motley Fool
08:58AM  Intra-Cellular Therapies stock down 15% after disappointing Phase 3 trial results MarketWatch
08:52AM  Intra-Celluar Therapies Falls Following Results For Treatment Of Bipolar Depression Benzinga
07:54AM  UPDATE 1-Intra-Cellular drug fails one of two bipolar depression studies; shares fall Reuters
07:18AM  Intra-Cellular drug fails one of two bipolar depression studies Reuters
07:14AM  Intra-Cellular announces positive results in late-stage trials of treatment for bipolar depression MarketWatch
07:00AM  Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression GlobeNewswire
Jul-06-19 02:45PM  The Week Ahead In Biotech: Conferences, Clinical Trial Readouts And Earnings Benzinga
Jul-05-19 02:49PM  Intra-Cellular Shares May Double on Bipolar Depression Data Bloomberg
08:43AM  Are Options Traders Betting on a Big Move in Intra-Cellular Therapies (ITCI) Stock? Zacks
Jul-02-19 08:00AM  Intra-Cellular Therapies Appoints Karen Patruno Sheehy, Esq. as Senior Vice President, Chief Compliance Officer GlobeNewswire
Jul-01-19 12:55PM  7 Stocks on Sale the Insiders Are Buying InvestorPlace +8.09%
Jun-26-19 02:06PM  Here is What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI) Insider Monkey
Jun-19-19 08:00AM  Intra-Cellular Therapies to Present at JMP Securities Life Sciences Conference GlobeNewswire
Jun-17-19 10:11AM  Before You Buy Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Consider Its Volatility Simply Wall St. +13.11%
08:39AM  Implied Volatility Surging for Intra-Cellular (ITCI) Stock Options Zacks
Jun-13-19 08:55AM  Intra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in Adults GlobeNewswire +8.63%
May-30-19 08:00AM  Intra-Cellular Therapies to Present at Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-20-19 08:41AM  2 Biotech Names See Directors Direct Cash to Their Shares TheStreet.com
May-17-19 03:14AM  Edited Transcript of ITCI earnings conference call or presentation 8-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-16-19 08:00AM  Intra-Cellular Therapies to Present at 2019 RBC Capital Markets Global Healthcare Conference GlobeNewswire
May-15-19 08:00AM  Intra-Cellular Therapies Announces Presentations on Lumateperone Schizophrenia Program at the American Psychiatric Association (APA) Annual Meeting GlobeNewswire
May-10-19 01:15PM  Such Is Life: How Intra-Cellular Therapies (NASDAQ:ITCI) Shareholders Saw Their Shares Drop 57% Simply Wall St.
May-08-19 04:06PM  Heres What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI) Insider Monkey
01:26PM  Intra-Cellular Therapies, Inc. (ITCI) Q1 2019 Earnings Call Transcript Motley Fool
07:42AM  Intra-Cellular: 1Q Earnings Snapshot Associated Press
07:30AM  Intra-Cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
May-02-19 08:00AM  Intra-Cellular Therapies to Host First Quarter 2019 Financial Results Conference Call and Webcast GlobeNewswire
Apr-29-19 08:56AM  Are Options Traders Betting on a Big Move in Intra-Cellular Therapies (ITCI) Stock? Zacks
Apr-16-19 08:00AM  Intra-Cellular Therapies Mourns the Passing of Co-Founder and Nobel Laureate, Dr. Paul Greengard GlobeNewswire
Apr-15-19 07:00AM  Intra-Cellular Therapies Presents Additional Results From Long-term Open Label Safety Study of Lumateperone at the 2019 Congress of the Schizophrenia International Research Society GlobeNewswire
Apr-02-19 11:40AM  Investors Who Bought Intra-Cellular Therapies (NASDAQ:ITCI) Shares Three Years Ago Are Now Down 61% Simply Wall St. +7.91%
Mar-26-19 07:00AM  Intra-Cellular Therapies Continues to Strengthen Its Commercial Leadership Team; John A. Bardi Appointed as Senior Vice President, Market Access, Policy and Government Affairs GlobeNewswire
Mar-05-19 08:00AM  Intra-Cellular Therapies to Present at The Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Mar-04-19 06:01PM  Edited Transcript of ITCI earnings conference call or presentation 27-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Feb-27-19 11:30AM  Intra-Cellular Therapies Inc (ITCI) Q4 2018 Earnings Conference Call Transcript Motley Fool +6.66%
07:30AM  Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update GlobeNewswire
Feb-21-19 08:00AM  Intra-Cellular Therapies to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-20-19 08:00AM  Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast GlobeNewswire
Intra-Cellular Therapies, Inc., a biopharmaceutical company, engages in developing novel drugs for the treatment of neuropsychiatric and neurodegenerative disorders. The company is developing its lead drug candidate, lumateperone for the treatment of schizophrenia, bipolar disorder, behavioral disturbances associated with dementia, autism, and other CNS diseases. It is also developing ITI-002 that inhibits the enzyme phosphodiesterase type 1; ITI-214 for Parkinson's disease; and ITI-333, for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Satlin AndrewEVP and Chief Medical OfficerJan 09Sale26.1611,573302,75011,338Jan 10 09:14 PM
Mates SharonChairman, President & CEOJan 09Sale26.1641,8951,095,9731,204,707Jan 10 09:09 PM
Halstead MichaelEVP and General CounselJan 09Sale26.1619,638513,730191Jan 10 09:06 PM
Hineline Lawrence J.SVP of Finance CFOJan 09Sale26.1619,638513,73018,800Jan 10 09:03 PM
Mates SharonChairman, President & CEOJan 08Option Exercise2.7460,000164,4001,246,602Jan 08 09:11 PM
Mates SharonChairman, President & CEOJan 06Sale30.2845,5981,380,8801,144,707Jan 08 09:11 PM
Halstead MichaelEVP and General CounselJan 06Sale30.3421,458651,007191Jan 08 09:02 PM
Hineline Lawrence J.SVP of Finance CFOJan 06Sale30.2921,458650,00318,800Jan 08 09:00 PM
Halstead MichaelEVP and General CounselJan 02Sale32.437,807253,214191Jan 03 09:17 PM
Hineline Lawrence J.SVP of Finance CFOJan 02Sale32.437,807253,16519,800Jan 03 09:16 PM
Mates SharonChairman, President & CEOJan 02Sale32.4517,478567,2301,144,707Jan 03 09:14 PM
Mates SharonChairman, President & CEODec 31Option Exercise2.746,00016,4401,162,185Jan 03 09:14 PM
Hineline Lawrence J.SVP of Finance CFODec 23Option Exercise2.749,60026,30434,832Dec 26 04:06 PM
Hineline Lawrence J.SVP of Finance CFODec 23Sale25.5015,032383,31619,800Dec 26 04:06 PM
Neumann MarkEVP, Chief Commercial OfficerOct 16Sale8.256,77455,8866,674Oct 17 04:50 PM
Alafi Christopher DDirectorSep 10Buy10.26485,0004,974,6784,673,270Sep 11 04:30 PM
Alafi Christopher DDirectorAug 30Buy8.52125,0001,065,2134,188,270Sep 04 06:24 PM
Alafi Christopher DDirectorJun 12Buy11.73170,0001,993,793170,000Jun 14 05:23 PM
MARCUS JOEL SDirectorMay 29Option Exercise12.4520,000249,00041,671May 31 04:35 PM
Alafi Christopher DDirectorMay 14Buy12.56100,0001,256,3504,053,270May 15 06:03 PM
Hineline Lawrence J.SVP of Finance CFOFeb 27Option Exercise2.7410,40028,49626,232Mar 01 07:41 PM
Hineline Lawrence J.SVP of Finance CFOFeb 27Sale15.001,00015,00025,232Mar 01 07:41 PM
open in yahoo | open in reuters | open in google